First Manhattan’s Rigel Pharmaceuticals RIGL Stock Holding History

First Manhattan’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200	Closed	-$3K	–	1433
2020 Q2	$3K	Sell	200 -280	-58%	-$5.04K	﹤0.01%	1296
2020 Q1	$7K	Sell	480 -80	-14%	-$1.7K	﹤0.01%	1195
2019 Q4	$11K	Buy	560 +260	+87%	+$5.35K	﹤0.01%	1129
2019 Q3	$5K	Hold	300	–	–	﹤0.01%	1211
2019 Q2	$7K	Hold	300	–	–	﹤0.01%	1212
2019 Q1	$7K	Buy	+300	New	+$6.86K	﹤0.01%	1234
2015 Q2	–	Sell	-15,737	Closed	-$561K	–	1484
2015 Q1	$561K	Buy	+15,737	New	+$431K	﹤0.01%	498

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Manhattan's RIGL Position: Q3 2020 in Review

First Manhattan sold out of Rigel Pharmaceuticals (RIGL) in Q3 2020, closing a stake of 200 shares — an estimated $3K sold.

First Manhattan first reported a position in RIGL in Q1 2015 and held it in 7 quarters. The position peaked at $561K in Q1 2015. 138 funds tracked by Wall St. Rank hold RIGL as of Q3 2020.

First Manhattan reported no remaining Rigel Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
First Manhattan sold 200 Rigel Pharmaceuticals shares in Q3 2020, an estimated $3K.
First Manhattan first reported a position in Rigel Pharmaceuticals in Q1 2015 and held it in 7 quarters.
First Manhattan's Rigel Pharmaceuticals position peaked at $561K in Q1 2015.
138 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2020.

Based on First Manhattan's 13F filing for Q3 2020, filed 12 Nov 2020.